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If using a sweetened citrus tastant (i.e., a chemical that stimulates the taste buds and 
produces a sense of taste) to coat a pill could make swallowing pills easier, this could 
have a considerable positive impact on the ability to swallow pills in healthy adults nd 
on those with identified swallowing difficulties who need to take a variety of oral 
medications. In this study, it was predicted that pills would be cleared from the pharynx 
more quickly and efficiently if a pill was coated with a tastant. Thus, the following study 
examined the effect of a pleasant citrus tastant on pill swallowing in healthy individuals 
(7 male; 17 female) aged 19–49 years (M = 27.83 years). Durational measures of 
swallowing were obtained from real-time ultrasound images of the oropharyngeal 
swallow. It was hypothesized that swallow durations would be shortest for citrus- oated 
tablets, followed by water swallows and then plain pills. Although results from statistical 
analyses did not support a quicker oropharyngeal swallow for one stimulus over another, 
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 The purpose of swallowing food and liquid is more than just to assuage hunger 
and satisfy the need to rid the mouth of excess secretions. Swallowing consistently takes 
place in social interactions as people gather around the table and discuss the day’s events. 
Joyous occasions, such as weddings and birthdays, would be mundane and bland without 
opportunities to swallow, and sad occasions would lose their sense of comfort. We 
swallow to live but most people also live to swallow as chefs spend years in culinary 
institutes to make what is nutritious also full of flavor. What we place in our mouths is 
not only about survival but it is also about taste and activating our tongue’s taste 
receptors in positive ways so that we would want to continue to consume the same 
substances. The act of swallowing is critical to remaining in good health, especially as 
people age and find themselves having to take more and more pills. These compact 
transporters of nutrients and carefully manufactured chemicals are most often unflavored 
and can be large. As a result, swallowing tablets can be a challenge, albeit an often 
necessary one. For that reason, the following study is intended to determine if adding a 
tastant (i.e., a chemical that stimulates the taste buds and produces a sense of taste) t  a 
pill can facilitate swallowing ability or make swallowing easier. 
 
Introduction to Swallowing 
 The act of swallowing in healthy individuals is commonly taken for granted. 
Humans place food in their mouths, chew, and swallow without much thought regarding 
the underlying processes and movements that are responsible for the physical act of 
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swallowing. However, there are 25 pairs of muscles in the mouth, pharynx (throat), 
larynx (voice box), and esophagus actively involved in the four-stage process of 
swallowing (Kendall, 2008). 
 The preparatory stage, the only stage of swallowing in which action is almost 
completely voluntary, occurs exclusively in the oral cavity. It is in this stage that food is 
tasted and either accepted by the individual for ingestion, thus initiating the entire process 
of the swallow, or rejected as a noxious substance and expectorated. The bolus, a mass of 
food particles, is positioned and moved by the tongue between each row of teeth for 
mastication (responsible muscles: temporalis, masseter, and medial and lateral pterygoid). 
It is mixed with saliva to dilute the bolus to a consistency adequate for swallowing and to 
lubricate the bolus to ease transfer from the mouth to the esophagus. The buccinator 
muscle within the cheeks prevents residue from accumulating within the buccal cavity, a 
space between the gums and the cheek. Anterior bolus loss, or spillage of the bolus from 
the front of the mouth, is inhibited by the sphincteric action of the orbicularis oris muscle 
surrounding the lips, while premature bolus spillage into the pharynx is prevented 
through elevation of the posterior portion of the tongue against the soft palate (Ardran 
1951; Groher, 1997; Kendall, 2008; Logemann, 1998). 
 During the oral stage, the bolus is propelled from the oral cavity to the pharynx. 
To initiate motion and propulsion, the surface of the tongue contacts the alveolar ridge 
immediately behind the teeth. As the soft palate elevates through contraction of the 
levator palati muscle, the posterior tongue depresses through action of the hyoglossus and 
styloglossus muscles, thereby forming an opening to the pharynx. As the surface of the 
tongue applies pressure to the alveolar ridge and anterior portion of the hard palate 
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immediately behind it in a series of rapid motions, the bolus makes its way toward the 
back of the oral cavity on the dorsum (i.e., back) of the tongue. In the meantime, the soft
palate contacts the posterior pharyngeal wall to close off the nasopharynx (nasal 
passageway) from bolus penetration; additional protection of the nasopharynx is provided 
by constriction of the side walls of the nasopharynx. The hyoid bone, located above the 
laryngeal structures, begins to elevate and move forward as the mylohyoid and 
geniohyoid muscles at the base of the tongue contract to start the pharyngeal swallow. 
 The pharyngeal stage involves passage of the bolus through the pharynx and into 
the esophagus. The mandibular muscles, which include the medial and lateral pterygoid, 
masseter, and temporalis muscles stabilize the tongue base as the bolus is m ved in a 
posterior direction by the tongue’s piston-like actions (Kendall, 2008; Logemann 1998). 
The pharynx elevates through contraction of the palatopharyngeus muscles and the 
pharyngeal walls stiffen, beginning a descending stripping wave. The pressure produced 
by actions of the tongue and pharyngeal walls in a closed cavity moves the bolus back 
while the suprahyoid muscles pull the hyoid and the attached larynx (hyolaryngeal 
complex) in an anterior and superior direction. The hypopharyngeal chamber expands 
which causes a decrease in pressure in the pharyngoesophageal segment, making it
possible—in concert with the tongue’s piston-like action against the superior and middle 
pharyngeal constrictor muscles—for the bolus to make its way through the pharynx and 
into the upper esophagus (Groher, 1997). As the hyoid and larynx elevate, the thyrohyoid 
muscles contract, the intrinsic laryngeal muscles aid to partially closethe vocal folds, and 
the epiglottis lowers over the laryngeal opening to help prevent aspiration (i.e., entranc  
of foreign particles into the airway below the level of the vocal folds). Breathing is 
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stopped for a centisecond. At the entrance of the esophagus, the upper esophageal 
sphincter, which is normally closed through contraction of the cricopharyngeus muscle, 
relaxes and opens. Hyolaryngeal elevation aids in creating a traction force to op n the 
upper esophageal sphincter at the entrance to the esophagus (Logemann, 1998). The 
bolus can now enter the esophagus. The force of pharyngeal contractions will move the 
bolus from the level of the glottic opening once the bolus is in the pharyngoesophageal 
segment (Kendall, 2008). The velum, hyoid, and epiglottis will return to their original 
resting state and the larynx will open for respiratory duties once again. 
 In the esophageal stage, the bolus moves through the esophagus and reaches the 
stomach through a peristaltic wave ranging in speed and intensity; smooth and striate
muscles of the esophagus contract in a coordinated fashion (Kendall, 2008, Logemann, 
1998). Contraction of the smooth muscles is controlled by motor nuclei in the brainstem 
and contraction of the striated muscles is controlled by the autonomic nervous system. At 
the bottom of the esophagus, the lower esophageal sphincter, which is normally 
contracted, is relaxed during swallowing so that the bolus can be transferred into the 
stomach. Secondary and tertiary esophageal peristalsis may occur when primary
peristalsis fails to get the bolus completely down the esophagus. Secondary peristalsis 
occurs when receptors sense distension of the esophageal lumen. Only the smooth 
muscles of the esophagus are active in tertiary peristalsis (Kendall, 2008). 
 
Taste 
 Taste receptors, which are composed of modified epithelial cells that regene ate 
every 7–10 days, are responsible for the ability to taste a substance (Cowart, 1988). 
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Although they are found primarily in the papillae, or taste buds, of the tongue, they are 
also present throughout the oral cavity on the soft and hard palate, pharynx, larynx, 
epiglottis, and upper esophagus. It is uncertain if taste receptors in these lat r loc tions 
possess the same perception qualities as those on the tongue, although they have been 
found to perceive nonsaline chemicals (Bradley, 2000; Pritchard, 1991). 
 Within each taste receptor is a taste cell. When a tastant combines with saliva, this 
novel mixture enters through the receptor’s taste pore to produce taste perception. 
Although specified regions of the tongue perceive taste qualities with more intensity than 
other areas of the tongue, all areas of the tongue can perceive all taste qualities (Collings, 
1974; Pelletier, 2007). Thus, the notion that sensation for sweet is found at the anterior 
portion of the tongue, salty at the antero-lateral sides of the tongue, sour at the mid-lateral 
sides of the tongue, and bitter at the posterior portion of the tongue is simply a myth. 
Umami, a fifth taste receptor that perceives flavor elicited from glutamate as found in 
meat, milk, and fish, was discovered in 2000 (de Araujo, Kringelbach, Rolls, & Hobden, 
2003). 
 A total of four types of papillae are innervated by different cranial nerves to allow 
for the perception of taste: fungiform, foliate, circumvillate, and filiform. Fungiform 
papillae comprise approximately 24% of all lingual taste buds in their location along the 
anterior portion of the tongue (Pelletier, 2007). While 25% of fungiform papillae are 
innervated by the chorda tympani, a branch of the facial nerve (CN VII), the other 75% is 
innervated by the trigeminal nerve (CN V). Found on the mid-posterior portion of the 
tongue, foliate papillae comprise approximately 28% of the tongue’s total taste buds. 
Innervation is derived from both the glossopharyngeal nerve (CN IX) as well as the 
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chorda tympani branch of the facial nerve (CN VII). Circumvillate papillae can be found 
in a V-shaped formation on the dorsal posterior portion of the tongue. Although there are 
typically 8–12 of these papillae on the tongue, they house they greatest number of taste
buds—approximately 48%—and are innervated exclusively by the glossopharyngeal 
nerve (CN IX). Filiform papillae are the most plentiful of all papillae; however, these 
structures located along the dorsal portion of the tongue are the only papillae that do not 
contain taste buds; they are responsible for lingual tactile perception (Pelletier, 2007). 
With regards to nonlingual taste receptors, the small collection that is found on the soft 
palate is innervated by the greater petrosal branch of the facial nerve (CN VII). Although 
not consistently found on the velum, fungiform papillae in this location have been found 
to perceive salt. 
 Although there appears to be little change in the number of taste receptors from 
birth to middle age, the number of circumvillate and foliate papillae has been 
demonstrated to decrease in the elderly (Cowart, 1981). In addition, salivary flow 
reduction, development of thicker saliva, degeneration of papillae, and loss of keratinizd 
cells which provide protection to tissues of the oral cavity can be attributed to changes in 
gustatory sensation (Cowart, 1981). 
 
Taste Development 
 Limited evidence has been found regarding taste preferences in the fetus 
(DeSnoo, 1937; Liley, 1972), which has been shown to develop specialized taste cells 
between the 7th and 8th weeks of gestation and mature taste buds between the 13th and 
15th weeks (Bradley, 1967). The fetus is consistently exposed to a changing environment 
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as fetal receptors make contact with ingested amniotic fluid. In addition, taste receptors 
may be stimulated by secretions within the fetal salivary system (Weiffenbach, Daniel, & 
Cowart, 1980).  
 There are more data detailing a significant role for taste preferences i  the 
regulation of food intake in the newborn. Infants’ diets consist primarily of formula or 
milk. However, infants emerge from the womb with more sophisticated preferences a d 
taste detection ability than may be expected. Infant facial expression has provided 
information that infants are able to differentiate sour and bitter from each other and from 
salt, and are able to discriminate sweet as opposed to non-sweet tastes (Rosen tein & 
Oster, 1988; Steiner, 1973, 1979; Steiner, Glaser, Hawilo, & Berridge, 2001). In 
particular, a small (n = 12) study carried out by Rosenstein & Oster (1988) found that 2-
hour-old newborns with no previous experience with tastants responded to sucrose with 
facial relaxation and sucking. Infants reacted to sour, bitter, and salty solutions by, for 
example, similarly wrinkling their noses and lowering and raising their brows in the 
upper- and mid-facial regions. However, reactions differed in the lower-facial region with 
infants displaying lip pursing in response to sour solutions and mouth gaping in response 
to bitter solutions. Differentiating facial expressions in the lower-facial region were 
absent for salty solutions. 
 As is employed in the discrimination of visual stimuli, infant sucking patterns 
have been used reliably to provide evidence of taste preference. Crook (1978) found that 
infants’ sucking patterns were reliably lengthened when provided .4 M (molar solution) 
of sucrose and shortened when given .1 M, .3 M, or .6 M sodium chloride during a pause 
in sucking. Newborns between 1 and 3 days old have been found to exert increased 
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sucking pressure in the anterior portion of the tongue in response to increases in the 
sweetness of a solution, seen as facilitating ingestion; disruption of sucking and increases 
in posterior tongue pressure have been found to occur in response to quinine 
hydrochloride and sodium hydrochloride solutions (Nowlis, 1977; Nowlis & Kessen, 
1976). Additional studies have reported differing levels of heart rate and respiration 
(Crook & Lipsitt, 1976), and lateral tongue movements (Weiffenbach, 1977) for different 
tastes. 
 A combination of genetic and environmental influences is considered responsible 
for newborns’ preference for sweet substances and aversion to bitter and sour substances 
(Bartoshuk, 1990; Birch, 1999; Cowart, 1981). At a rudimentary level, parents provide 
infants with genes. As a result, they pass on genetic predispositions that promote the 
ingestion of substances containing nutrients required for growth and survival (Birch, 
1999). In turn, taste aversions may be the result of years of genetic adaptation, thereby
explaining infants’ aversion to bitter tastes; poisons are typically bitter (Cowart, 1981; 
Rosenstein & Oster, 1988). Preference for specific tastes is also the result of an infant’s 
exposure to the taste. For example, Crystal and Bernstein (1995, 1998) found that infants 
whose mothers experienced moderate-to-severe vomiting during pregnancy show 
preference for the taste of salt. In addition, children will only eat those foods t  which 
they are exposed by their caretakers. This, for example, explains infants’ growing 
preference for salty foods between 3 and 6 months since this is the period of time in 
which most infants are weaned from sweet formula and are exposed to salty foods (Harris 





 Sour stimuli produce secretion of the largest amount of saliva of all taste stimuli 
(i.e., sour, sweet, bitter, salty, umami). The amount of saliva produced affects bility to 
perceive sour taste in adults since perception is largely related to salivary flow rates in 
addition to salivary pH. Sourness is a reflection of a substance’s acidity, or pH. When a 
sour taste, which is elicited by weak acids and is associated with the presence of 
hydrogen, is introduced to the taste receptors, salivation increases in response. As a 
result, the bicarbonate concentrations, which serve as a buffer for the perception of sour 
by influencing the availability of hydrogen, increase with salivary pH in an attempt to 
bring the pH to a homeostatic level. Therefore, the intensity of sour perception is 
diminished due to the increases in salivary pH (Spielman, 1990). Those with higher 
salivary flow rates have been found to possess higher sour-taste thresholds than those 
with low salivary flow rates (Norris, Noble, & Pangborn, 1984). Thus, adults who 
possess high salivary flow rates and pH will consistently rate sour stimuli as more intense 
than those with lower salivary flow rates and pH (Norris et al., 1984). Despite the depth 
of information found regarding adults’ perception of sour taste, data regarding the 
mechanics of sour perception in infants and children are less clear-cut. 
 Research suggests that preference for sour solutions intensifies beyond early 
infancy. Whereas older infants (aged 2–24 months) have demonstrated decreased 
ingestion of sweet solutions when citric acid is added (Vazquez, Pearson, & Beauchamp, 
1982), 23% of 15- to 20-month-old infants (Blossfeld et al., 2007) and 35% of 5- to 9-
year-old children (Liem & Mennella, 2003) have been found to show preference for 
extremely sour fruit juice. Some research has suggested that the sour preferences 
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demonstrated by young children are related to a growing desire to seek thrills and explore 
the world in addition to a willingness to try unfamiliar foods (Liem & Mennella, 2003; 
Liem et al., 2004; Urbick, 2000). In addition, a moderately-sized study conducted via 
questionnaire consisting of 50 children suggested that the more citric acid within a 
sucrose solution that 8- to 11-year-old boys reported to prefer was related to a greater 
amount of fruit they reported to consume (Liem, Bogers, Dagnelie, & de Graaf, 2006). 
This finding suggests that acceptance of sour taste could be related to children’s 
acceptance of fruit. 
 Research with young adults has provided the bulk of information regarding how 
taste preferences change with age. Although taste preferences typically vary by individual 
depending on concentration of stimulant, in general, adults regard sour tastes as negative, 
along with strongly salty and bitter tastes, while considering sweet and mildly salty tastes 
as pleasant (Moskowitz, Kumaraiah, Sharma, Jacobs, & Sharma, 1976). While increasing 
concentrations of sweet may enhance the pleasantness of a substance, at no point does 
increasing concentration of sour or bitter stimuli heighten rating of pleasantness 
(Moskowitz et al., 1976). 
 Few studies have been conducted regarding taste preferences in older adults. 
However, there is research to support that an age-related decline in preference o  sweet 
substances, especially in females, exists. Enns, Van Itallie, and Grinker (1979) revealed 
that, when sweetness preference is assessed via hedonic scaling and paired comparison 
techniques using standard solutions of sucrose (.056–1 M), older adults’ (M = 71.1 years) 
sweet preferences are relatively similar to those of children (M = 10.6 years) and young 
adults (M = 18.7 years). However, the older female adults reported liking the stronger 
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sucrose solutions less than the other groups evaluated. Similarly, Laird and Bree  (1939) 
found that, when rating five gradations of juice sweetness, older female adults preferred 
pineapple juice that was less sweetened, in comparison to the preferences of any other 
group investigated (i.e., participants aged 18–40 years and 50–68 years). 
 
Olfaction 
 Although taste is primarily discussed when referring to sensory experiences 
exhibited while eating, olfaction, or the sensation of smelling, must be elicited in 
combination with taste to produce flavor. Perceptions derived from taste (gustation), 
smell (olfaction), and chemical chemesthesis (chemical irritation) combine within the 
oral cavity to produce a sense of flavor (Bartoshuk, 1990). Olfactory receptors are located 
at the top of the nasal cavity, under the eyes. When the sensation of a food with a strong
smell, such as onions, is inhaled via the nostrils, tactile receptors along the inside of the 
nose are stimulated to the point that it is possible to directly sense the pungent odor’s path 
to the olfactory receptors. However, when eating less volatile foods, odors make their 
way from the mouth to the nasal cavity where the olfactory receptors pick them up. 
Localization cues to specific receptors are absent for food odors when eating. Therefore, 
the entire experience of eating is localized to the mouth which receives the tangible, 
tactile input (Bartoshuk, 1990). 
 The foods people ingest are driven by olfaction after a holistic connection is made 
cognitively between the smell of a food and what happens when it is tasted and, 
subsequently, consumed. It is only after the olfactory characteristics of a fo d are 
processed that taste cues, in addition to textural cues, are factored into the sensory 
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experience used to identify a food (Bartoshuk, 1990). Most vitamins within foods are 
present in small amounts and are not perceived at either the olfactory or taste levels. 
However, when vitamins are present in concentrated tablet form, olfaction and taste can 
combine to produce a flavor that may not be considered pleasant to swallow. 
 
Swallowing Pills and Medications 
 It can be assumed that most healthy individuals pay little-to-no attention to the
actions involved when swallowing, nor are they actively aware of the physical actions 
that make the process possible. Swallowing is an innate action performed in the healy, 
normally-developing fetus as early as the 12th week of gestation and is present at birth 
(Humphrey, 1970). Swallowing, although partially under volitional control in the 
preparatory and oral stages, is not under volitional control in the pharyngeal and 
esophageal stages. Therefore, perhaps the only instances in which some of the small but 
essential actions involved in swallowing are actively perceived are when a pice of food 
or liquid enters the trachea and the person must cough to expectorate the particle to avoid 
blocking the airway, and when a person has to swallow a pill. In the preparatory stage of 
swallowing, a person grinds a bolus to a certain consistency and size so that it can be 
easily swallowed (Kendall, 2008; Logemann, 2008). On the other hand, pill swallowing 
requires a person to swallow whole a substance of a set texture (typically solid) and set 
size without the luxury of being able to chew it to a comfortable consistency. To obviate 
choking, a person must ensure that the tablet is in a comfortable position in the mouth 
(i.e., in the back of the mouth where a bolus is typically positioned right before the 
swallow reflex occurs), using water or other lubricants (e.g., applesauce) to force the pill 
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down. Because very few people go through life without being prescribed medication or 
taking vitamins, being able to successfully swallow tablets is a critical life skill. 
 Medications are prescribed for individuals in order to cure illness, help them feel 
better or allow their bodies to function better. However, if medication regimens ar not 
adhered to because of problems with swallowing tablets, an individual may face a higher 
incidence of morbidity and mortality—especially if one possesses a swallowing disorder, 
or dysphagia (Carnaby-Mann & Crary, 2005). Even in healthy individuals, problems 
swallowing tablets are quite commonly reported. A questionnaire conducted by general 
practitioners in Norway found that 1 out of 3 women and 1 out of 6 men have issues 
swallowing tablets (Andersen, Zweidorff, Hjelde, & Rødland, 1995). Moreover, a 
national survey conducted in 2000 indicated that 40% of adults have problems 
swallowing pills, prompting 14% to delay taking a dose of their medication and 8% to 
completely skip taking a dose (DeRoche, Macclaren, & Sonies, 2000). Size of a pill has 
been determined as the most important inhibiting factor—as opposed to shape, coating, or 
surface area—in clearing a pill through to the esophagus. Not surprisingly, large-sized 
pills have been determined as more difficult and less comfortable to swallow than smaller 
ones (Channer & Vijee, 1986; Overgaard, Hojsted, Hansen, Moller-Sonnergaard, & 
Christrup, 2001). 
 In an attempt to make pills more conducive to swallowing, health practitioners 
often advise patients to alter solid doses through crushing or opening up capsules and 
mixing them in such substances as applesauce or pudding. Instead of swallowing pills 
with water, juice is sometimes used. Within healthcare settings, nurse practitioners often 
feel pressured to deliver medication to patients in a timely manner. However, this task 
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becomes a challenge when delivering medication to those who are either bereft of th  
mental capacity to consent to medication administration, expectorate their medication, or 
simply refuse to take pills (Stubbs, Haw, & Dickens, 2008). When working with such 
patients, surreptitious administration is not uncommon, especially if alternate mod s of 
medicine administration (i.e., transdermal, parental/injectable, buccal, rect l, intranasal, 
or sublingual) are unavailable. However, pharmaceutical manufacturers are typically 
purposeful in how they develop and market medication; pills are placed in a form that 
allows for proper absorption in the gastrointestinal tract in the correct anatomic area (e.g., 
esophagus, stomach, intestine) and ensures that the medication releases active agents at
the correct rate (Stubbs et al., 2008). Not only does alteration of certain medication doses 
decrease medication efficacy and cause it to be unpalatable, but alteration of medication 
doses can also quickly increase a medication’s toxicity, reduce chemical stability of a 
medication (e.g., as in amlodipine, isosorbide, mononitrate, dinitrate, atorvastatin, 
topiramate, cabergoline, pergolide), produce physiochemical drug-drug interactions, or—
in the case of steroids, hormones, and cytotoxins—even cause harm to the administrator 
handling the medication from exposure (Griffith & Tengnah, 2007; Stubbs et al., 2008; 
Wright et al., 2006). Further, crushing of tablets can cause cross-contamination with ther 
medications when mortar and pestles or pill crushers are not cleaned out, and some of the 
tablet can be lost in the crushing device, inhibiting the patient from receiving the full 
dose. In addition, if medication is added to a food substance, it is highly possible that the 
patient will receive a smaller dose of the medication if the patient does not consume the 
entire food portion (Stubbs et al., 2008). Data reported from the UK Patient Safety 
Agency between 2005 and 2006 indicated that modified-release opiate tablets and 
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cytotoxics were the medications most commonly altered in medication-related incidents 
(Stubbs et al., 2008). A review conducted by Stubbs et al. (2008) found that, out of 266 
instances of dosing modification, 4.5% were of medications that pharmaceutical 
manufacturers specifically indicated should not be crushed or opened. Those medications 
most frequently altered were those targeting the central nervous system (55.6%), 
followed by cardiovascular (22.6%), endocrine (10.9%), musculoskeletal (3.4%), 
gastrointestinal (3.4%), and respiratory (0.4%) system medications, as well as 
antibacterial medications (3.8%). Problems with the organ systems these medications 
target are frequently cited as causes of dysphagia. 
 Another method of easing pill swallowing is to split tablets where they are scor d 
and take each half separately. A study investigating patients’ rationales for subdividing 
tablets indicates that, of the 30% of medications (275 prescriptions) divided upon the 
initiative of patients themselves, 13% were split to make pills easier to swallow 
(Rodenhuis, De Smet, & Barends, 2004). Medications that can be broken without 
compromising drug safety or effectiveness are commonly scored. However, a small 
research study conducted in the Netherlands via patient questionnaire of 140 medications 
has indicated that not all scored tablets are easy to break, and many break unevenly 
(Rodenhuis, De Smet, & Barends, 2003). These complaints were reported for 15% and 
28% of prescriptions, respectively. At times, these issues result in loss of a portion of a 
tablet and, consequently, the medication’s potency if a medication’s therapeutic range is 
narrow. Although pill splitters provide a mechanical means of breaking a tablet and ase 
any difficulty experienced from breaking a tablet by hand, they have not been found to 
accurately split pills into equal halves (Van Santen, Barends, & Frijlink, 2002). Negative 
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experiences with pill administration could give rise to poor compliance with medication 
regimen. 
 Medication acceptance is a common issue, especially with adolescents and 
children. Negative attitude toward wanting to swallow pills has been found to play a role 
in medication non-acceptance (Hansen, Tulinius, & Hansen, 2008); however, reports 
from healthcare practitioners and parents have indicated that poor medication acceptan e 
can primarily be attributed to problems with swallowing pills due to size and taste 
aversion (Hansen, Tulinius, & Hansen, 2008; Jahnsen & Thorn, 1987). Many pills are 
oral administration only and, although no data exist detailing if children are less resi tant 
to medication in liquid suspension, there is less medication available in liquid form than 
in tablet form. In addition, as a child grows, it becomes more difficult to provide 
necessary doses in liquid suspension (Polaha, Dalton, & Lancaster, 2008). Therefore, 
learning how to tolerate swallowing pills is largely unavoidable. 
 A large (n = 304) study requiring parents of children and adolescents aged 0–26 
years to complete a mailed survey found that, although medication refusal is more 
common in adolescents who are chronically ill and required to swallow more pills than 
those who are healthier, those ill adolescents evidence better pill swallowing abilities 
than those adolescents who are healthier and swallow fewer pills (Polaha, Dalton, & 
Lancaster, 2008). Perhaps as a result of necessity and increased practice, there is some 
evidence that individuals’ difficulties swallowing tablets diminish with age (Andersen, 
Zweidorff, Hjelde, & Rødland, 1995). 
 Antibiotics such as clarithromycin or sparfloxacin, medications containing 
alkaloids, such as quinine or berberine, and the antipyretic acetaminophen are bitter in
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taste (Suzuki et al., 2003). To mask the unpleasant taste, medications have been 
chemically modified, coated with polymers, microencapsulated, or placed in capsules. 
However, in order to prepare medications that require a large amount of active substance 
in one dose, the pills must often be manufactured in bulky, large forms which, as 
discussed, pose another pill swallowing complication (Suzuki et al., 2003). Because it is 
critical that older adults ingest medications without difficulty, in addition to pill size, pill 
taste must be taken into account when considering type of medication prescribed and 
compliance with a successful medication regimen. 
 
Effects of Temperature and Tastants on Swallowing 
 Many attempts have been made to change the characteristics of a bolus in order to 
improve swallowing function in patients with dysphagia. In particular, introducing a cold 
bolus to the swallow system has been found to aid in triggering the pharyngeal swallow 
(Bisch, Logemann, Rademaker, Kahrilas, & Lazarus, 1994; Miyoka et al., 2006). 
Furthermore, increasing the size of a bolus has been found to extend the duration of upper 
esophageal sphincter opening and protective airway closure as well as contribute to 
posterior movement of the tongue base and pharyngeal wall contraction (Bisch et al., 
1994; Hiss, Strauss, Treole, & Stuart, 2004). Taste, which is a powerful sensory stimulus, 
has also been used to facilitate swallowing. Specifically, ingesting a sour bolus has been 
demonstrated to reduce swallow onset time, oral transit time, pharyngeal transit time, and 
increase the efficiency of the oropharyngeal swallow in individuals with dysphagia, in 
addition to contributing to reduced levels of aspiration (Logemann et al., 1995; Sciortino, 
Liss, Case, Gerritsen, & Katz, 2003).  
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 Given that sensory loss is a significant factor in the manifestation of dysphagia—
especially in individuals post-stroke—it would seem logical to increase sensory iput to 
compensate for the deficiency. Sour is one of the strongest tastes an individual can 
experience. Sensed primarily by receptors on the sides of the tongue as wella large 
number of additional oral receptors, the sensation of sour taste travels to the nucleus
tractus solitarius of the brain’s medulla via the facial nerve, the chorda tympni, and the 
otic ganglion. Once in the nucleus tractus solitarius, second-order relay neurons contact 
neurons in the pons which contact the lateral hypothalamus, amygdala, and thalamus, 
which contain fibers that have connections to the sensory cortex. Strongly-flavored sou  
taste increases receptor response, thus increasing stimulation to the nervous system and 
cortical swallowing centers and sending a clear and robust signal that a sw llow is 
imminent (Logemann et al., 1995). As a result of this taste stimulation, the threshold 
required to trigger a pharyngeal swallow is effectively lowered making the swallow more 
efficient. 
 The seminal study in support of the use of sour bolus in swallowing was 
conducted by Logemann et al. (1995). Nineteen individuals who had suffered a stroke 
(M = 64 years) and 8 individuals who had experienced other neurogenic etiologies such 
as closed head injury, multiple sclerosis, AIDS, brain tumor, and anoxia (M = 38.5 years) 
were included. Each participant experienced a delayed onset in the oral stage of 
swallowing and/or a delay in triggering of the pharyngeal stage. Particip nts were asked 
to swallow 3 boluses each of 1mL and 3mL liquid barium and then 3 boluses each of 
1mL and 3mL 50% Real Lemon Juice with 50% liquid barium while undergoing 
videofluoroscopy. Both groups of participants demonstrated a significant improvement in 
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onset of oral swallow when given the sour bolus. Improvements in reduced oral transit 
time and pharyngeal transit time, and improved oropharyngeal swallow efficiency were 
also seen, all of which facilitate a safer swallow and reduce the risk of aspiration. Those 
participants who had experienced stroke demonstrated significantly reduced pharyngeal 
swallow delay time, while those participants who had other neurogenic deficits 
demonstrated significantly reduced aspiration. Although participants uniformly reported 
the sour bolus as not pleasant, they found it to be tolerable. Pelletier (2007) explained th t 
citric acid inherent in the use of lemon was responsible for producing the sensation of 
sour in this study’s participants. The high dose of citric acid may have stimulated 
chemesthesis. This sensation has been demonstrated in other stimulants—such as 
carbonation (Bulow, 2003)—to reduce penetration, aspiration, and oral transit times, as 
well as decrease retention of a bolus. Logemann et al. (1995) explained that the sour 
bolus could contribute to increased salivation which, in turn, increases bolus volume. 
Research supports that increased bolus volume to 5mL reduces oral transit time and 
pharyngeal delay time, thus supporting its use for patients with dysphagia (Bisch et al. 
1994). 
 Pelletier and Dhanaraj (2006) conducted a study in which 10 healthy individuals 
(M = 25.5 years) were delivered a total of 11 taste stimuli, including citric acid 
monohydrate and barium sulfate-citric acid. In a randomized order, participan s were 
given each 10mL stimulus in both moderate and high concentrations. Participants rinsed 
their mouths with water between trials to ensure that previous tastes wer not perceived. 
Peak amplitude and duration of each swallow were analyzed and participants were asked 
to rate each sample for palatability. Peak lingual pressures for the moderate 
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concentrations of citric acid monohydrate and barium sulfate-citric acid were 
significantly higher than water, despite the fact that the high barium sulfate-citric acid 
stimuli were rated the least palatable of all of the stimuli. This finding is important in 
support of citric acid stimuli since the amount of lingual pressure generated when the 
tongue presses against the hard palate is important to propel the bolus to the back of the 
oral cavity and elicit a safe swallow. Although healthy older individuals are typically able 
to create enough lingual pressure when swallowing, those who are less healthy may have 
decreased pressure reserve and may not generate enough lingual pressure, thereby placing 
them at higher risk for aspiration (Robbins, Levine, Wood, Roecker, & Luschei, 1995). 
Thus, added citrus tastants could make swallowing safer and more efficient. 
 Despite evidence supporting decreased oral transit time with sour stimuli there s 
evidence that suggests that its unpalatable taste actually increases oral transit time. 
Hamdy, Jilani, Price, Parker, Hall, and Power (2003) conducted a study which included 
65 healthy adult participants (M = 45 years) and 22 participants who had experienced 
acute stroke (M = 67 years). Participants took part in a water swallow test which required 
them to quickly but comfortably drink 50mL of water while hyolaryngeal elevations (i.e., 
swallows) were counted. Mean interstimulus interval was calculated (i.e., tim  to 
complete the task/number of swallows during the task) as well as mean swallowing 
volume velocity (i.e., volume drunk/time taken) and mean swallowing volume capacity 
(i.e., volume drunk/number of swallows). In a single-blinded, randomized manner, the 
water was presented at either room temperature (21°C), at a cold temperature (4°C), at 
room temperature with 5mL (10%) citrus lemon juice added, or at a cold temperature 
with 5mL citrus lemon juice added. Between trials, participants were asked to drink 
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25mL of room temperature water to rinse the mouth of any residual stimulus. In contrast 
to previous studies, it was found that the combination of cold and citrus water slow dthe 
speed of swallows as well as reduced swallowing capacity in both healthy and acute 
stroke participants. The interstimulus interval was unaffected in all particints, except in 
the healthy <60-year-old participants when they had received the cold citrus stim lus; the 
interstimulus interval decreased. It was reasoned that the heightened sensory input 
produced by the sour stimulus may have been considered noxious, thereby causing 
participants to alter their swallowing behavior (i.e., swallow more slowly) by paying 
close attention to the task of swallowing. Moreover, a protective mechanism that 
decreases bolus volume and alters swallowing behavior in order to reduce the chance of 
aspiration of a noxious stimulus may have taken place. 
 There is also research which both supports and questions use of sour bolus in 
swallowing. Palmer, McCulloch, Jaffe, and Neel (2005) conducted a small study in which 
bipolar hooked-wire electrodes were inserted into the mylohyoid, anterior belly of the 
digastric, and geniohyoid muscles of 8 healthy participants (age range = 21–37 years). 
Participants were asked to hold either 3mL water or 3mL lemon solution (50% water and 
50% ReaLemon) in their mouths and—when directed—to swallow five trials of each 
presented in random order. Electromyography (EMG) was conducted to examine onset of 
EMG activity for each muscle, offset of EMG activity for each muscle, and EMG at the 
time of the swallow command. Strength of muscle activation was estimated. A significant 
effect was found for tighter approximation of muscle activation across the onsets f the 
three muscles with use of the sour bolus. In support of the use of sour bolus, the study 
found that more than half (4 out of 7) of the participants experienced quicker swallow 
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onset times and all participants experienced closely-timed activation of all three muscles 
when a sour bolus was provided. It was rationalized that the engagement of increased 
taste receptors caused these robust responses. Yet, the fact that almost half (3 out o 7) of 
the participants demonstrated longer swallow onset times raises questions regarding the 
use of a sour bolus. Additionally, a trend for increased duration of muscle activity with 
sour bolus was observed; however, there was no significant effect to strongly support use 
of sour bolus. 
 In all of the above studies, it is important to consider the methodological 
differences which may account for some of the varied results in swallow timing. For 
example, participants in Logemann et al. (1995) and Palmer et al. (2005) were asked to 
swallow small 1mL and/or 3mL boluses, whereas participants in Hamdy et al. (2003)
were requested to quickly and comfortably swallow a 50mL bolus while being timed. In 
the latter study, which focused on sequential swallows, participants kept liquid in their 
mouths during swallows, which may have caused hesitation in swallowing and, as a 
result, increased oral transit times due to the unpleasant bolus taste. Although the oral 
stage was greatly slowed, once the pharyngeal swallow was enacted, a strong swallow 
could be expected. In addition, not all studies included individuals with medical 
conditions. Given that other swallowing treatments, such as chin tuck, have been shown 
to reduce or eliminate aspiration in persons with dysphagia and have no significant efect 
on swallowing performance in healthy individuals (Bulow, 2001), results from Pelletier 
and Dhanaraj (2006) and Palmer et al. (2005) with healthy participants may not 
completely generalize to ill individuals. 
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 Sour stimuli are not palatable to many individuals. Therefore, research has been 
conducted investigating means of providing individuals with sour stimuli that are more 
palatable than very sour substances but possess the same effectiveness. However, 
sweetness has been found to suppress sourness in healthy individuals as evidenced by 
Pelletier, Lawless, and Horne (2004). In their first experiment, 19 healthy older 
participants (M = 72.2 years) and 21 healthy younger participants (M = 22.6 years) tasted 
and rated the intensity of sucrose sweetness and sourness in 9 liquid samples. Each 
sample consisted of deionized water, sucrose, citric acid, or a combination of citric acid 
monohydrate and sucrose. Their second experiment consisted of 33 healthy older 
participants (M = 74.2 years) and 39 younger participants (M = 21.7 years) who tasted 
and rated 6 samples in the same manner as in the first experiment. The significant 
difference between the two experiments was that the second used aspartame ins ead of 
sucrose since it is shown to add less viscosity and volume to liquid barium while still 
sweetening it, making such a solution (if found to be effective) preferable for 
videofluoroscopic studies (Pelletier, Lawless, & Horne, 2004). However, regardl ss of 
the type of sweetener used (i.e., sucrose or aspartame), the effects of sour were 
suppressed similarly in both young and older participants. This occurred even when the 
temperature of a sweet-sour stimulus was reduced, as discovered in an extension of the 
second experiment. Thus, it is possible that coating a pill with a sweetened sour tastant 
may not significantly affect swallowing ability. However, this is unknown given that 




 In general, several modes of sour stimuli application have been conducted. One 
mode of application is to add a sour stimulus to a bolus in order to stimulate oral and 
pharyngeal taste receptors. This has specifically been shown to shorten swallow onset 
time, oral transit time, pharyngeal transit time, and pharyngeal delay as well as reduce 
aspiration as seen on videofluoroscopic swallow studies (Logemann et al., 1995). 
Another mode of application entails applying the sour stimulus to a specific 
oropharyngeal area (e.g., anterior faucial pillars) with a lemon glycerin swab or lemon-
flavored probe. This has specifically been shown to enact a quicker swallow response 
using surface electromyography which demonstrated earlier activation of infrahyoid and 
submental muscles (Ding, Logemann, Larson, & Rademaker, 2003; Sciortino et al., 
2003). 
 Although there are studies that point to increased oral transit time in swallowing 
with a sour bolus, there are several more studies that support its ability to decrease 
oropharyngeal swallow speed and improve swallow efficiency. There is a dearth of 
studies on this topic that have been conducted with larger sample sizes and participants 
who are as uniform as possible in their diagnosis and site(s) of lesion. And finally, there 
are few studies regarding the ability to swallow pills and—perhaps most significant to the 
present study—no known studies investigating the effect of sweetened citrus tastants nd 
pill swallowing. 
 
Rationale and Objectives 
 The purpose of the present study is to determine if a tablet coated with a pleasant 
citrus-flavored tastant will improve ease of swallowing pills in healthy adults. There is a 
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paucity of scientific data on the effect of tastants on pill swallowing in the adult 
population. Difficulty swallowing pills is, however, a common complaint among adults. 
If using a sweetened citrus tastant to coat a pill could make swallowing pills easier, this 
could have a considerable positive impact on the ability to swallow pills in healthy adults, 
older individuals, and on those with identified swallowing difficulties who need to take a 
variety of oral medications. It was anticipated that swallowing would be mor efficient 
and comfortable if a pill would be cleared from the pharynx more quickly and with 
greater ease. The following questions will therefore be addressed in the present 
investigation: 
• Will time for oropharyngeal swallow be shortest for citrus-coated tablets, 
followed by water swallows and then plain pills? 
• Will duration of hyoid movement required to complete an oropharyngeal swallow 
differ between a large pill coated with citrus tastant and an uncoated large pill? 
• Will the time to complete a pill swallow be affected by the participant’s attitude 






 A total of 24 healthy adults (7 male; 17 female) between the ages of 19 and 49 
years (M = 27.83 years; SD = 9.28), who were determined bereft of significant issues 
swallowing pills or known swallowing disorders were selected for this study. Participants 
were actively recruited via mass email (Appendix A) to undergraduate students in an 
introductory hearing and speech sciences class receiving class credit for participation, and 
to University of Maryland graduate students in the speech-language pathology and 
audiology programs, who received neither academic credit nor monetary compensation 
for participation. Participants were not excluded from the study on the basis of gender, 
race, ethnic origin, or sexual preference. 
 Prior to acceptance in the study, positive responses to any one or more of the 
following six screening questions, either provided via email correspondence or phone 
consult, were used to determine exclusion from study participation: 
(1) Have you ever had an allergic reaction to calcium? 
(2) Do you have or have you ever had hypercalcemia (high amounts of calcium in the blood)? 
(3) Have you ever had kidney stones? 
(4) Are you taking any medications that may be contrai dicated with increased calcium intake 
(gallium nitrate (Ganite), cellulose sodium phosphate (Calcibind), etidronate (Didronel) phenytoin 
(Dilantin) or a tetracycline antibiotic to treat aninfection (such as doxycycline, minocycline, 
Vibramycin))? 
(5) Have you ever had a problem swallowing (dysphagia)? 
(6) Are you allergic to any of the following: glycerin, sorbitol, xanthan gum, neotame, sodium 
citrate, citric acid, potassium sorbate, sodium benzoate, propylene glycol, N & A flavors, 
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cellulose, croscarmellose, titanium dioxide, vegetable magnesium stearate, FD&C Yellow No 5 
Lake, FD&C Blue No 1 Lake? 
 
Those participants selected were requested to defer taking a calcium supplement on those 
days in which they were scheduled to take part in the study. In addition, participants were 
instructed not to have a high-fiber meal (e.g., bran, whole-grain cereal or bread, fresh 
fruits), ingest high amounts of alcohol, or drink more than 8 cups of coffee on each day 
they took part in the study because there is possibility for fiber, alcohol, and caffeine to 
affect calcium metabolism. High amounts of fiber have been found to result in reduced 
urinary calcium excretion, although reduced calcium absorption occurs (Shah et al., 
2009), whereas alcohol (De Kalbfleisch, Lindeman, Ginn, & Smith, 1963; Wolf et al., 
2000) and possibly caffeine (Barger-Lux & Heaney, 1995) result in increased calcium 
excretion and reduced calcium absorption. 
 
Procedures 
Preliminary Data Collection 
 All trials took place in the ultrasound laboratory located in 0147 Lefrak Hall, 
Department of Hearing and Speech Sciences, University of Maryland, College Park. The 
institutional review board of the University of Maryland, College Park approved the 
protocol before commencement of the study. Individual informed consent was obtained 
from all participants before they took part in the study. 
 Prior to participation in the actual pill swallowing study, on the first day of 
experimental measures, participants answered a short written series of screening 
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questions (Appendix B) that pertained to pill swallowing ability and habits, and calcium 
intake. Six of the 16 questions had been presented to individuals when initially screened 
on the phone or via email for study participation. Once again, any one positive response 
to one or more of the initial phone/email screening questions (Appendix B, items 1, 3, 4, 
5, 7, or 16) would have indicated elimination from the study. For each of the two 
sessions, if one positive response was provided for either item 2 (“Have you taken any 
calcium supplements today?”) or item 6 (“Have you had a high-fiber meal today, ingested 
high amounts of alcohol, or more than 8 cups of coffee today?”) a participant would be 
asked to return on an alternate day for the session. No participants were eliminat d or 
asked to return on an alternate day for a session on the basis of their responses. 
 A brief oral-motor examination was performed assessing the strength and 
movement of the tongue and lips to rule out oral and perioral structural or functional 
abnormalities, all of which are essential to normal swallowing function. The tongue is 
one of the major organs involved in preparing an ingested substance for swallowing; in a 
healthy individual, its strength creates sufficient negative pressure against the alveolar 
ridge to thrust a substance to the posterior oral cavity through to the pharynx, and its wide
range of motion allows for manipulation of the substance in preparation for swallowing. 
Therefore, any signs of tongue weakness or decreased range of motion could indicate 
swallowing difficulties. Ability to maintain symmetry when moving lips is an indication 
of lip strength important for both building negative pressure for swallowing in addition to 
retaining substances to be swallowed within the oral cavity. Vocal quality was assessed to 
ascertain if there was a possibility that airway protection when swallo ing could be 
compromised. It was not deemed necessary to conduct a full oral-motor examination 
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since targeted participants were healthy and any general difficulties swallowing would be 
ascertained from questionnaires. Individuals were asked to round and retract their lips, 
extend, elevate, depress, and lateralize their tongue, say “ah,” and push their tongu  tip 
against an individually wrapped, disposable tongue depressor. Inability to conduct any of 
the above tasks with full range of motion, aperture, or strength would lead to elimination 
from the study; however, no participants were eliminated based on their results on this 
exam.  
 In addition, to ensure that participants had no swallowing disorders, they were 
asked to fill out a published and widely-used questionnaire (“Speech-Language 
Pathology Swallowing Questionnaire,” Appendix C; Sonies et al., 1987) that pertains to 
swallowing ability. Possible responses were rated on a scale of 1 to 4, where “1” = 
normal, none, never, “2” = mild, a little, occasionally, “3” = moderate, a fair bit, often, 
and “4” = severe, lots, usually-always. Exclusion from the study was based on 
swallowing difficulty typical in a population with dysphagia, per one response f “3” or 
“4” on items 5–8, 19, or 25 (“Do you have difficulty swallowing liquids?”; “Do you have 
difficulty swallowing purees, soft, or sticky food?”; Do you have difficulty swallowing 
solids?”; “Have you eliminated any foods from your diet because of difficulty 
swallowing?”; “Does food or pills ever stick in your throat?”; “Do you have pain when 
swallowing?”) or three or more responses of “3” or “4” to the remaining questions with 
the exception of the following items which would not indicate a swallowing difficulty: 
items 3 (“Do you notice drooling at night”), 11 (“Are you a fast eater?”), 12 (“Are you a 
slow eater?”), 14 (“Do you experience discomfort with hot or cold temperatures?”), 15 
(“Do you experience discomfort with spicy food?”), and 20 (“Do you experience 
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heartburn/indigestion?”). It was reasoned that drooling at night could be indicative of 
sleeping with one’s mouth open or allergies, eating either fast or slow could be related to 
eating schedules or habit, temperature and spice discomfort could be related to lowered
thresholds/increased sensitivity to taste stimuli or cultural factors, and 
heartburn/indigestion could be related to gastrointestinal issues or complications with the 
esophageal stage of swallowing, which was not within the scrutiny of this study. None of 
the participants had to be eliminated from the study based on their responses to this 
questionnaire. 
 
Active Data Collection 
 Upon successful completion of the questionnaires and oral-motor screening 
examination conducted during the first session only, each participant was provided the 
following directions in order to obtain baseline information concerning an individual’s 
oropharyngeal swallowing speed when ingesting water alone, and to train participants 
regarding how to swallow the pills: 
 
You will be asked to swallow three 30cc medicine cups of water. First, tilt your head back to move 
the water to the back of your mouth. When you are ready to swallow, quickly tilt your chin toward 
your chest and swallow hard. Each time, a small ultrasound transducer coated with a tiny bit of 
water soluble gel will be placed under your chin so we can record the movements of your tongue 
and hyoid bone as you swallow. We will also record the time it takes to complete a swallow. There 





All participants viewed their ultrasound swallow study in real-time to famili rize them to 
the procedure. Immediate playback allowed the investigator to determine that the data 
gathered were clear and measurable. 
 In this controlled, within-subject study, each participant was slated to swallow a 
total of 6 calcium tablets, either with tastant (“Pill Glide,” orange cream-fl vor) added or 
without tastant (plain). The following directions were given: 
 
You will be asked to swallow three calcium tablets wi h 30cc water. Do not chew the tablets. A 
small ultrasound transducer coated with a tiny bit of water soluble gel will be placed under your 
chin so we can record the movements of your tongue, hyoid bone, and pill as you swallow and the 
time it takes to complete a swallow. There is no discomfort, risk or, danger in this procedure. 
Please hold the pill and water in your mouth until you are asked to swallow. If you are unable to 
swallow the tablet, you may spit it out or you may request additional water if needed. In addition 
to rinsing your mouth with 30cc water between trials, you will be given at least a minute between 
swallows. 
 
 Calcium tablets (CVS calcium oyster shell, 500mg; ingredients: cellulose [plant 
origin], cellulose coating, croscarmellose, titanium dioxide color, vegetable magnesium 
stearate, FD&C Yellow No. 5 Lake, FD&C Blue No. 1 Lake) were chosen based on their 
large size (oblong shape with dimensions [length x width x height] of 2.0mm x 0.7mm x 
0.5mm) and availability without tastant. Calcium is essential for bone growth, 
neurotransmitter secretion, muscle contraction, digestion, and blood coagulation. 
Recommended minimum daily intake for adolescents and adults is 1200–1500 mg/day 
(Marcus, 1996) with no guidance or limitations given regarding maximum daily intake 
(Theobald, 2005). Thus, even though the dose (1500 mg) exceeded the lower end (1200 
 
32 
mg) of the recommended minimum daily intake, the human body is known to absorb only 
enough calcium to fulfill dietary requirements; typically 20%–30% of intake is absorbed 
in the gastrointestinal tract. Any calcium determined by the body to be in excess is 
excreted through the urine and feces (Marcus, 1996; Theobald, 2005).  
 Large pills were chosen for this research based on the data suggesting that they 
are more difficult and less comfortable to swallow than small pills (Channer & Vijee, 
1986; Overgaard et al., 2001). Thus, it was considered that if a citrus-coated tastant could 
make swallowing large pills easier, it would have positive impact on pill swalo ing with 
healthy adults, older individuals, and those with swallowing difficulties. Pills would be 
swallowed more rapidly and efficiently and cleared from the throat without difficulty, 
thus having a positive impact on health and safety during swallowing. 
 To obtain a subjective measure from participants regarding attitude toward pill 
size and ease of swallowing, in the first session, the investigator asked the following 
question before beginning the first pill trial, while showing an individual the tablet: “Do 
you think this pill will be easy to swallow?” 
 As per directions provided to participants, each tablet was administered with 30cc 
water at room temperature. If more water was needed, the investigator recorded the 
amount needed to swallow the pill. If participants were still unable to swallo  the pill 
despite additional water, it was determined that they would be excluded.  
 The study was divided into two separate sessions spread out over a series of two 
days (3 tablets in session 1; 3 tablets in session 2). The first session was determined to 
take approximately 30–45 minutes; the second session, 15–20 minutes. To control for 
order effects of tastant versus no tastant, participants’ dosage order was counterbala ced 
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using all possible combinations of pill order with the following exception: no participant 
could receive three of the same type of pill in one session. Thus, it was possible that some 
participants would receive two dosages of a tablet with tastant or two dosages of  plain 
tablet in a given session. However, no participant received three tastant-coated tablets or 
three plain tablets in a session. Tablets with added tastant were coated completely 
(sprayed 2 times) with the tastant immediately before administration. The investigator’s 
back was turned from participants at all times during pill preparation. In each instance, 
the pill was lightly shaken in its medicine cup to fully coat the tablet with tastant and/or 
to initially blind participants to type of pill they were receiving. Participants were not 
informed regarding the tastant prior to the study. Furthermore, presence of the tastant was 
not discussed in either study session. 
 A colorless orange cream-flavored tastant (“Pill Glide”; ingredients: purified 
water, glycerin, sorbitol, xanthan gum, neotame, sodium citrate, citric acid) was chosen to 
coat tablets based on the literature which supports the effects of citrus bolus in reducing 
swallow onset time, transit time of a bolus across the surface of the tongue, transit time of 
the bolus down the throat, and increasing the efficiency of the swallow in individuals 
who have suffered a stroke in addition to contributing to reduced levels of aspiration 
(Logemann et al., 1995; Sciortino, Liss, Case, Gerritsen, & Katz, 2003). 
 To obviate changes occurring in the composition of the calcium pills from acidity 
levels present in orange or lemon juice, an organic substance could not be directly 
applied to the surface of the pills. Although “Pill Glide” protects the integrity of the 
tablet, the tastant’s ingredients, including glycerin, produces a slippery surface when 
applied to the pills, which study participants may or may not have noticed. Non-flavored 
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“Pill Glide” was unavailable at the time of this study to coat the plain pills so that the 
plain tablets and the tablets with tastant would possess the same exact surface texture. 
Therefore, a confounding factor may have been introduced. 
 
Measurements 
 The duration of the oropharyngeal swallow was determined by a frame-by-frame 
analysis conducted via a small, portable real-time ultrasound machine (GE Healthcare 
Logiq Book, 2004, Wauwatosa, WI). From ultrasound, the investigators obtained black 
and white moving digitized images of the tongue as the pill moved over the surface of the 
tongue into the pharynx during swallowing. As soon as a pill was placed in the mouth 
and prior to the swallow, the ultrasound timer was started and durational information, in 
seconds and number of image frames, appeared on the image for measurement of total 
oropharyngeal swallow duration. Total duration of the oropharyngeal swallow was 
recorded in real-time and measured with frame-by-frame analysis of ultrasound images as 
the time elapsed from the first frame in which the hyoid bone moved superiorly and 
anteriorly from its resting position to the frame in which the hyoid returned to its original 
position. Extra swallowing gestures (i.e., extra movement of the hyoid bone, excess 
tongue movement) and false starts were recorded; however, they were omitted from 
overall swallowing measurements. For all stimuli, the number of false starts observed 
was variable both between individuals and within a participant’s trials. Per trial, only the 
one completed oropharyngeal swallow that pertained to the variable being looked at (i. ., 
baseline swallow with water only; swallow water along with the pill) wasmeasured. A 
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total of 9 swallows were measured per participant: 3 with water only, 3 with plain tablets, 
and 3 with citrus-coated tablets. 
 Real-time ultrasound provides a cost-effective, dynamic, noninvasive, safe (no 
radiation), and efficient method by which the oropharyngeal swallow can be assessed. 
Ultrasound can specifically image the soft tissue structures of the oral cavity whose 
movement is essential to enactment of the swallow. It works by reflecting sound waves 
off interfaces between different tissues or materials. The air interface at the surface of the 
tongue allows for an efficient reflection of sound, thereby providing clear images of the 
lingual musculature both at rest and in motion. Contrast material does not need to be 
provided to distinguish internal features of the oral cavity from a bolus and there are no 
known bioeffects regarding this procedure which is used routinely to image the fetus 
(Brown & Sonies, 1997; Miller & Sonies, 2008; Sonies, Chi-Fishman, & Miller, 2003; 
Sonies, Parent, Marrish, & Baum, 1988; Watkin & Miller, 1997). 
 For all trials, the participant was seated comfortably in a relaxed, upright osition. 
A small, 1-inch in tip length ultrasound transducer (GE Healthcare 8C-RS, Wauwatosa, 
WI) which provides soundwave frequencies between 4MHz and 10MHz, was placed 
submentally (underneath the chin) midline on the skin covering the floor of mouth 
muscles, angling the ultrasound beam upwards approximately 90° from a horizontal 
plane in relationship to the transducer to produce a sagittal view of both the tongue (i.e., 
genioglossus, geniohyoid, and mylohyoid muscles) and oral cavity, and then backwards 
approximately 10° from midline sagittal to visualize the upper surface of the tongue and 
shadow of the hyoid bone, as depicted in Sonies, Chi-Fishman, and Miller (2003). Each 
time, a small amount of ultrasound water soluble transmission gel (“LiquaSonic”) was 
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used to maintain adhesion between the skin and the surface of the transducer during 
imaging. The investigator stood to the right side of each participant, anchorig the 
transducer underneath the participant’s chin. The investigator’s focus remained on 
transducer positioning throughout ultrasound recording in order to ensure that the 
ultrasound image angle did not shift secondary to the participant’s head movement. To 
ensure that the ultrasound transducer was placed correctly and consistently, th  
investigator held the transducer so that its notch faced away from the participant and was 
always midline and positioned straight. The resulting mid-sagittal ultrasound image 
displayed the hyoid on the right and the tongue tip on the left in each moving image. 
 Duration of each oropharyngeal swallow was calculated in milliseconds based on 
image frame numbers provided by the ultrasound machine. To obtain this measurement, 
1000ms was divided by the number of frames per second recorded by the machine for a 
given scan recording (i.e., 44). This resulting number (i.e., 22.73) was multiplied by the
beginning frame number (when the hyoid began to move upward in position) subtracted 
from the end frame number (when the hyoid returned to its original position). Although 
calculations were based on frames given their heightened accuracy as compared to 
seconds, data are reported in milliseconds, which is a more intuitive measure. Imag s 
were captured on-line and stored on recordable compact discs for later analysis. 
 Each swallow trial was coded numerically on the ultrasound image and in a log 
book based on whether the pill was plain or coated with a tastant. Plain pills were coded 
with a 1, 2, or 3 and pills with tastant were coded with a 4, 5, or 6 at the end of the 
participant’s identification number. Baseline swallows of water only were coded a, b, or 
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c. Coding provided the basis for grouping the data for later analysis without revealing the 
actual identity of each participant. 
 
Post-Measures 
 At completion of the second appointment, participants were asked the following 
two questions to gauge their individual experience with the pills: 
1) Did you find the pill difficult to swallow? 
2) Did you find that the tastant made the pill easier to swallow? 
 
Inter-rater and Intra-rater Reliability  
 To ensure that oropharyngeal swallow measurements and time calculations for 
swallows via ultrasound were consistently and accurately obtained, the investigator 
became fully familiarized with the ultrasound machine used throughout the duration of 
the study. Familiarization included methods for initiating and stopping recording, 
methods for saving each trial (including naming files) for later review, bracing the 
ultrasound transducer for a clear sagittal view, regardless of participants’ movements, 
calculating swallowing time by using frame-by-frame measurements on the ultrasound 
machine, and knowing when measurements should begin and end based on hyoid 
movement.  
 A preliminary training procedure/pilot was completed under the supervision of the
experienced advisor to ensure the investigator’s good judgment when looking for markers 
delineating the beginning and end of hyoid movement indicating the oropharyngeal 
swallow. Swallows for 2 individuals (18 trials) were recorded on ultrasound for all
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stimuli (i.e., water only, plain pills, pills with tastant) and analyzed. Close agr ement 
between the experienced advisor and investigator for 17 out of 18 trials (94%) denoted 
successful training for ultrasound swallowing analysis. 
 Following completion of data collection, oropharyngeal swallowing time for 15%
of total trials (32 trials) was calculated to determine both inter- and intra-ra er reliability. 
The same swallows were rated independently by both the investigator and the 
experienced advisor, who were both blind to swallowing conditions when conducting 
measurements. Identifying information (code numbers printed on the upper left-hand 
corner of the real-time image) for type of swallow was hidden from view until after 
calculations were made. In each instance, calculations were compared to the 
investigator’s previously recorded calculations determined 2–3 weeks prior. Pearson’s 
product moment correlation revealed .90 reliability both between raters (inter-rater) and 




 The mean time for oropharyngeal swallow was calculated in milliseconds f r each 
participant over the three swallowing trials for each condition (i.e., baseline water, plain 
pill, pill with tastant). Figure 1 shows results for all three types of swallo s. Tables 1, 2, 
and 3 show individual data results in milliseconds for all trials. 
 





















































Plain Pill Pill with Tastant Baseline Water Only
max=2598.80
(SD=418.61) (SD=356.14) (SD=402.24)




Table 1. Oropharyngeal Swallow Duration for Plain Pills 










Duration of Mean 
Oropharyngeal 
Swallow (ms) ID # Start End Start End Start End 
F260231 122 185 1431.99 104 156 1181.96 220 288 1545.64 1386.53 
F220331 295 341 1045.58 154 198 1000.12 370 406 818.28 954.66 
F210436 284 359 1704.75 264 354 2045.70 270 309 886.47 1545.64 
M320536 93 124 704.63 52 119 1522.91 81 143 1409.26 1212.27 
F230638 158 192 772.82 213 247 772.82 251 324 1659.29 1068.31 
M350738 127 200 1659.29 108 180 1636.56 125 177 1181.96 1492.60 
F490838 100 256 3545.88 127 254 2886.71 115 175 1363.80 2598.80 
F270938 90 171 1841.13 99 160 1386.53 205 244 886.47 1371.38 
F401038 95 154 1341.07 145 191 1045.58 108 144 818.28 1068.31 
F4611314 115 156 931.93 87 134 1068.31 160 206 1045.58 1015.27 
F4912314 160 210 1136.50 125 168 977.39 127 168 931.93 1015.27 
M2113314 83 124 931.93 208 257 1113.77 198 242 1000.12 1015.27 
F1914322 198 238 909.20 359 420 1386.53 160 196 818.28 1038.00 
M2415322 98 136 863.74 134 176 954.66 101 151 1136.50 984.97 
M2116324 148 187 886.47 125 164 886.47 118 177 1341.07 1038.00 
F2417324 106 148 954.66 110 143 750.09 154 190 818.28 841.01 
M2318324 124 221 2204.81 153 215 1409.26 133 220 1977.51 1863.86 
F2819324 112 170 1318.34 157 204 1068.31 158 196 863.74 1083.46 
F2320325 178 210 727.36 192 231 886.47 216 249 750.09 787.97 
F2021329 193 224 704.63 163 195 727.36 159 185 590.98 674.32 
M1922329 176 202 590.98 161 193 727.36 142 169 613.71 644.02 
F2523329 129 169 909.20 149 181 727.36 184 216 727.36 787.97 
F222445 140 168 636.44 158 198 909.20 140 208 1545.64 1030.43 
F292545 103 137 772.82 323 370 1068.31 127 178 1159.23 1000.12 
  Mean Oropharyngeal Swallow Time for PLAIN PILL 1146.60 
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Table 2. Oropharyngeal Swallow Duration for Pills with Tastant Added 











ID # Start End Start End Start End 
Duration of Mean 
Oropharyngeal 
Swallow (ms) 
F260231 230 275 1022.85 244 295 1159.23 97 144 1068.31 1083.46 
F220331 206 287 1841.13 104 151 1068.31 130 162 727.36 1212.27 
F210436 215 296 1841.13 153 268 2613.95 275 316 931.93 1795.67 
M320536 112 158 1045.58 79 119 909.20 72 133 1386.53 1113.77 
F230638 155 187 727.36 206 255 1113.77 316 370 1227.42 1022.85 
M350738 144 244 2273.00 139 195 1272.88 212 305 2113.89 1886.59 
F490838 121 235 2591.22 160 219 1341.07 153 195 954.66 1628.98 
F270938 194 257 1431.99 130 165 795.55 156 194 863.74 1030.43 
F401038 84 140 1272.88 146 180 772.82 67 124 1295.61 1113.77 
F4611314 210 242 727.36 131 171 909.20 128 173 1022.85 886.47 
F4912314 103 183 1818.40 113 161 1091.04 128 178 1136.50 1348.65 
M2113314 207 251 1000.12 204 241 841.01 153 192 886.47 909.20 
F1914322 162 199 841.01 139 180 931.93 141 171 681.90 818.28 
M2415322 117 154 841.01 102 145 977.39 119 155 818.28 878.89 
M2116324 142 180 863.74 137 174 841.01 141 172 704.63 803.13 
F2417324 120 161 931.93 179 220 931.93 111 147 818.28 894.05 
M2318324 124 198 1682.02 138 221 1886.59 149 242 2113.89 1894.17 
F2819324 121 152 704.63 118 164 1045.58 141 181 909.20 886.47 
F2320325 363 390 613.71 171 204 750.09 140 177 841.01 734.94 
F2021329 163 185 500.06 149 183 772.82 144 180 818.28 697.05 
M1922329 82 130 1091.04 142 173 704.63 149 176 613.71 803.13 
F2523329 176 203 613.71 145 210 1477.45 353 391 863.74 984.97 
F222445 107 142 795.55 115 161 1045.58 213 254 931.93 924.35 
F292545 148 196 1091.04 147 199 1181.96 96 150 1227.42 1166.81 
 Mean Oropharyngeal Swallow Time for PILL WITH TASTANT 1104.93 
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Table 3. Oropharyngeal Swallow Duration for Baseline Water Swallows 











ID # Start End Start End Start End 
Duration of Mean 
Oropharyngeal 
Swallow (ms) 
F260231 210 285 1704.75 130 193 1431.99 125 182 1295.61 1477.45 
F220331 78 141 1431.99 166 239 1659.29 347 436 2022.97 1704.75 
F210436 35 114 1795.67 215 283 1545.64 363 424 1386.53 1575.95 
M320536 28 72 1000.12 138 249 2523.03 292 443 3432.23 2318.46 
F230638 43 101 1318.34 228 271 977.39 396 440 1000.12 1098.62 
M350738 76 131 1250.15 230 295 1477.45 366 435 1568.37 1431.99 
F490838 47 92 1022.85 220 274 1227.42 377 426 1113.77 1121.35 
F270938 65 119 1227.42 236 297 1386.53 401 453 1181.96 1265.30 
F401038 135 172 841.01 292 326 772.82 426 457 704.63 772.82 
F4611314 102 150 1091.04 236 289 1204.69 356 398 954.66 1083.46 
F4912314 100 165 1477.45 244 292 1091.04 378 421 977.39 1181.96 
M2113314 75 113 863.74 231 277 1045.58 398 440 954.66 954.66 
F1914322 127 173 1045.58 277 311 772.82 429 460 704.63 841.01 
M2415322 90 156 1500.18 212 249 841.01 313 347 772.82 1038.00 
M2116324 114 153 886.47 211 264 1204.69 369 424 1250.15 1113.77 
F2417324 87 128 931.93 254 285 704.63 395 424 659.17 765.24 
M2318324 48 108 1363.80 210 279 1568.37 396 454 1318.34 1416.84 
F2819324 126 158 727.36 231 271 909.20 397 435 863.74 833.43 
F2320325 134 168 772.82 243 273 681.90 401 433 727.36 727.36 
F2021329 105 144 886.47 274 298 545.52 395 420 568.25 666.75 
M1922329 106 134 636.44 178 200 500.06 315 335 454.60 530.37 
F2523329 40 69 659.17 197 227 681.90 382 414 727.36 689.48 
F222445 86 137 1159.23 172 221 1113.77 269 315 1045.58 1106.19 
F292545 110 140 681.90 206 248 954.66 332 374 954.66 863.74 
 Mean Oropharyngeal Swallow Time for BASELINE WATER ONLY 1107.46 
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 Data were submitted to a 1-way repeated-measures analysis of variance 
(ANOVA) with the within-subject factor of type of swallow (plain pill, pill with tastant, 
baseline water only). No significant main effect was encountered, F (2, 23) = .19, p>.05, 
indicating that duration of oropharyngeal swallow did not significantly alter based on 
swallowing condition. At first glance (Figure 1), mean swallow time appears shortest for 
pills with tastant (M swallow time = 1104.93ms; SD = 356.14), followed by water-only 
swallows (M swallow time = 1107.46ms; SD = 402.24) and then plain pills (M wallow 
time = 1146.60ms; SD = 418.61). However, a trend cannot be substantiated. Of the 24 
participants, time for oropharyngeal swallow was shortest for pill with tastant for 10 
participants, followed by baseline water swallows for 11 participants, then plain pill for 3 
participants. Only 3 participants’ mean oropharyngeal swallowing measurements 
followed the progression of shortest (pill with tastant) to longest (plain pill) swallowing 
duration as displayed in Figure 1. 
 To investigate if a significant difference existed in duration of hyoid movement to 
complete an oropharyngeal swallow when ingesting large plain pills versus la ge pills 
with tastant, a planned comparison via paired t-test was conducted. Swallows were not 
shown to be significantly different, with t (23) = .73, p>.05, thereby indicating that time 
to swallow pills with tastant was not shorter than time to swallow plain pills.  
 In response to the follow-up question, “Did you find that the tastant made the pill 
easier to swallow,” 10 participants (42%) reported that the tastant aided in pill 
swallowing function while 14 participants (58%) reported that the tastant did not aid in 
pill swallowing function. To investigate if time to complete a pill swallow was affected 
by the participant’s attitude toward the tastant, data were submitted to a 2 (group) x 2 
 
44 
(condition) repeated-measures ANOVA with the within-subject factor of type of pill 
(plain or with tastant) and the between-subject factor of attitude toward the tastant in its 
ability to aid in pill swallowing. No significant main effect was found for the within-
subject factor of pill type, with F (1, 22) = 1.16, p>.05, or the between-subject factor of 
attitude toward the tastant in its ability to aid in pill swallowing, with F (1, 22) = .29, 
p>.05. Furthermore, no interaction was found for the within- and between-subject factors, 
with F (1, 22) = 3.62, p>.05, although the p-value approached significance at .07. 
Duration of oropharyngeal swallow was shortest for the pill with tastant for 6 of the 10 
participants who reported that the tastant aided pill swallowing. However, although some 
participants reported that the tastant aided in pill swallowing and slightly more than half 
of the participants indeed swallowed the pill with tastant in the shortest amount of time, 
there is no clear evidence to suggest that those participants actually benefited from the 
tastant. 
 Of the 24 individuals taking part in the study, a total of 7 participants (29%) 
reported having difficulty swallowing pills at some point in their lives per respon e to 
item 8 in the “Screening Questionnaire” (Appendix B). However, they did not swallow 
any differently than the other participants in the sample for any of the stimuli given. 
Large pills (tablets the size of the calcium pills) were consistently lis ed as difficult to 
swallow by all 7 participants; however 2 individuals also reported problems swallowing 
medium tablets (those tablets smaller than the size of the calcium pills but larger than the 
size of baby aspirins). Despite some participants’ contentions that swallowing pills was 
difficult for them, only 4 participants thought that the large calcium pill would be 
difficult to swallow when first shown the pill. Two held fast to their initial reaction, 
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considering the pill difficult to swallow after taking part in the study, whereas the other 2 
participants acknowledged that the pill was easier to swallow than initially believed. 
 A total of 17 participants (71%) reported taking at least one tablet a day (pill size 
not specified; range = 1–7 pills), 13 (54%) of whom reported taking two or more tablets 
per day (Appendix B, item 9). Thus, pill swallowing is an everyday task for most 
individuals in this sample which consists of people of varied ages. Those who took three 
or more pills per day (5 individuals) reported few-to-no difficulties associated wi h 
swallowing as per responses to the “Speech-Language Pathology Swallowing 
Questionnaire” (Appendix C). Only 2 participants reported that they were “fast eaters,” 
while 1 participant reported “difficulty chewing hard food.” Both eating quickly and 
chewing hard food rely heavily upon the preparatory stage of the swallow. Tongue 
movement during the preparatory stage is critical for efficiently moving the bolus 
between rows of teeth to allow for proper mastication and mixture of the bolus with 
saliva so that it can be swallowed easily. However, because chewing is not a task 
involved in pill swallowing—pills are swallowed whole!—adept tongue movement 
within this stage is essential to move the pill to the posterior portion of the tongue ad to 
create enough pressure against the alveolar ridge for the swallow to occur. 
 A total of 5 participants reported that they experienced discomfort with “hot or 
cold temperatures” or “spicy food” to either a moderate or severe degree per responses to 
the “Speech-Language Pathology Swallowing Questionnaire” (Appendix C). Of those 
participants, 2 experienced shortest mean oropharyngeal swallowing duration with the 
pill with tastant and longest with water only, while the remaining 3 participants 
experienced the opposite: longest mean oropharyngeal swallowing duration with the pill 
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with tastant and shortest with water only. It is possible that those in both groups possess 
lower thresholds for extreme stimuli and are therefore affected more by it. Those 
participants in the former group may therefore desire to clear the mouth of the strong 
stimuli and swallow quickly while those in the latter group may find the stimuli more 
difficult to negotiate within the mouth due to the intensity. Therefore, it may take those 
participants longer to swallow the strong stimuli and shorter to swallow water, which is 
considered a neutral stimulus in regard to taste. 
 Between study sessions 1 and 2, the following patterns for shortest oropharyngeal 
swallowing duration were observed: pill with tastant (session 1)/pill with tastant (session 
2) = 6 participants; plain pill/plain pill = 3 participants; plain pill/pill with tastant = 9 
participants; pill with tastant/plain pill = 5 participants; plain pill/tie between pill with 
tastant and plain pill = 1 participant. A total of 9 participants experienced the shortest 
oropharyngeal swallowing duration for their first of three pill swallowing trials in session 
1; whereas 7 participants experienced the shortest oropharyngeal swallowing duration for 
their first of three pill swallowing trials in session 2. No participants experienced shortest 
oropharyngeal swallowing duration for the first of three pill swallowing trials in both 




 The present study aimed to address the following questions: 1.) Will time for 
oropharyngeal swallow be shortest for citrus-coated tablets, followed by water swallows 
and then plain pills? 2.) Will duration of hyoid movement required to complete an 
oropharyngeal swallow differ between a large pill coated with citrus tastant and an 
uncoated large pill? 3.) Will the time to complete a pill swallow be affected by the 
participant’s attitude toward the tastant? In each case, results were not found to be 
statistically significant.  
 Several important explanations may be attributed to the lack of significant 
findings. One such explanation can be ascribed to a ceiling effect. A normal 
oropharyngeal swallow for water in healthy individuals aged 19–83 years is estimat d to 
be between 1 second and 1.5 seconds (approximate range = .91–1.69 seconds) (Sonies, 
Stone, & Shawker, 1984). While these data are in line with the present study’s findings 
for test swallows, there are no known normative data for healthy individuals when 
swallowing pills. In individuals with dysphagia, it has been researched that median time 
to swallow a 4.05mm tablet is 56.7 seconds, with a range of 5.2–323.0 seconds (Carnaby-
Mann & Crary, 2005). This is a much wider range than for those with normal swallowing 
function. It is possible that a healthy person’s speed in swallowing pills cannot impr ve 
significantly beyond that which is typical for swallowing water. Therefore, there would 
be no significant difference found in speed of swallowing between water, pills with 
tastant, or pills without tastant. 
 It can be surmised that oropharyngeal swallowing times could vary based on 
individual issues (e.g., organic disorder, phobia stemming from a bad experience/choking 
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episode). The present study recruited individuals without general swallowing difficulty, 
given the knowledge that if those with swallowing problems were to be actively 
recruited, all participants would need to have very similar issues (e.g., all participants 
with the same neurological insult, all participants who have experienced stroke in the 
same area of the brain) in order for valid results to be obtained. Some participants 
reported a history of difficulty swallowing large- and medium-size pills. However, it is 
possible that differences in oropharyngeal swallowing duration (for both water and pill 
swallows) are more exaggerated in disordered populations. Although positive results
were not demonstrated in the current study, procedures could be applied to those with 
dysphagia and known pill-swallowing problems to investigate if swallowing ability is 
enhanced when a citrus tastant is applied to a tablet. 
 It is also possible that results were affected by the sweetened characteristic of the 
orange cream-flavored tastant. It was regarded as pleasant to both the investigator and to 
several study participants (e.g., “like candy”), many of whom reported that it aided in 
swallowing the pill (e.g., “Anything that tastes pleasant you want to swallo  because it 
tastes good”). However, in one previous study, sweet citrus tastants in liquid form were 
found ineffective to enact improved swallowing function due to sweet suppression of the 
sour taste (Pelletier, Lawless, & Horne, 2004). The tastant used in the present study may 
not have produced enough chemesthesis (e.g., as is enacted by very sour lemon), which 
has been demonstrated in previous studies to show improvement in swallowing 
(Logemann et al., 1995; Pelletier, 2007; Pelletier & Dhanaraj, 2006). 
 Difference between robust results in previous studies and the present study may 
be a result of varied bolus consistency. In all previous studies on sour bolus, stimuli were 
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provided in liquid form (Hamdy et al., 2003; Logemann et al., 1995; Palmer, McCulloch, 
Jaffe, and Neel, 2005; Pelletier, 2007; Pelletier & Dhanaraj, 2006). However, a pill, as 
given in the current study, is a solid bolus that cannot alter in volume within parts of the 
mouth before it is swallowed. Therefore, general tongue movement to maneuver the 
bolus and subsequent initiation of the swallow may differ between consistencie , thereby 
allowing for differences in the duration of the oropharyngeal swallow. 
 Moreover, results may have been affected by texture changes procured when 
coating a tablet with manufactured “Pill Glide.” Adding organic substances, such a  
lemon or orange juice, directly to the surface of the pills would have caused changes in 
pill composition and, therefore, pill texture due to high acidity levels. Although “Pill 
Glide” protected the integrity of the tablet, the tastant’s ingredients, includig glycerin, 
produced a slippery surface when applied to the pills. Thus, an unavoidable confounding 
factor was introduced to the study. Therefore, it could not be determined conclusively if 
the results found were the product of taste alone, especially given participants’ varied 
impressions of the tastant. Although comments regarding the pill with tastant’s texture 
were not directly elicited through a targeted query, reactions to the pill’s sl ppery nature 
varied from neutral reports of “I didn’t notice” to positive reports of “it allowed the pill to 
slide down easier” to a few negative reports of “it was slimy.” Because non-tastant “Pill 
Glide” does not exist, it was not possible to rule out the confounding variable of slippery 
texture as either speeding up or slowing down swallows in the present study.  
 As with many studies within the field of speech-language pathology, a reduced 
number of study participants may prevent robust results from being obtained. This study 
was no exception. Given the small sample size of the present study, it is possible that if a 
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greater number of participants were included, the results may have reached, t t  very 
least, a trend indicating that oropharyngeal swallow time for pills with tasant is shorter 
than that for water only and then plain pills. In addition, an increased number of trials per 
participant for each condition may have yielded more accurate means and/or robust data 
to support a tendency or trend. This is especially salient because considerable varition 
between oropharyngeal swallow times was seen for many participants for the same type 
of swallow (see Tables 1, 2, and 3). 
 It is important to consider the reality that not only is the literature on pill 
swallowing scant, but also measurements in prior studies were made using different 
instrumental techniques than ultrasound, such as videofluoroscopy. In ultrasound, the 
oropharyngeal swallow is imaged and measured by examining movement of soft tissues 
(e.g., outline of superior tongue surface) and shadow of a solid structure (i.e., hyoid 
bone). Swallow measurements begin when the hyoid shadow moves in a superior and 
anterior direction and end when the hyoid shadow returns to its initial resting position. 
Meanwhile, maximal hyoid displacement corresponds with the pill passing into the 
hypopharynx over the lowered epiglottis along with posterior tongue contact with the 
palate (Sonies, Chi-Fishman, & Miller, 2003). At no point is it possible to measure the 
swallow simply by looking at the pill. However, videofluoroscopy images boney 
structures and the surface of only those soft structures (e.g., tongue) coated with barium, 
making it easy to interpret. Therefore, the oropharyngeal swallow would be assessed by 
looking at actual pill movement (if infused with barium) from when it passes the ramus 
of the mandible and subsequently passes through the upper esophageal sphincter (Watkin 
& Miller, 1997). Difficulty swallowing a pill would likely indicate problems with the 
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inter-relationship and sequencing of innervation between the floor of mouth muscles, 
tongue, and hyoid. In addition to difficulties moving the pill with the tongue in an 
anterior-posterior direction to the tongue’s posterior surface, there may be difficulty 
building enough lingual pressure against the alveolar ridge through agility nd strength of 
the floor of the mouth muscles. Insufficient negative pressure to propel the pill would
preclude initiation of hyoid movement for the oropharyngeal swallow. There may also be 
difficulties maintaining a wide enough aperture to the pharynx through elevation of the 
soft palate and posterior tongue depression. Although ultrasound is a fairly accurate 
instrument to envision the oropharyngeal swallow and, with proper midline sagittal 
transducer placement, can image the pill on the tongue and its movement to the posterior 
oral cavity, it cannot clearly show the tongue’s contact with the alveolar ridge and at no 
point can opening to the pharynx be viewed. Proof of a successful pill swallow is in the 
pill’s disappearance from the real-time ultrasound image. Of course, videofluoroscopy 
entails radiation exposure to the participant and therefore may be unethical for use in 
studies involving healthy individuals without swallowing problems. Videofluoroscopy 
can also be more costly than ultrasound to operate. However, it is possible that 
measurements within the present study would have an even greater level of 
discrimination if videofluoroscopy was the instrument of choice. Through barium 
coating, the tongue, the velum and their movements can be clearly imaged and the path of 
the pill can be traced from the mouth to the upper esophageal sphincter, or lower. Yet, 
alternatively, it is possible that a measure such as videofluoroscopy would have shown 
greater differences in the duration of the oropharyngeal swallow both between and withi  
participants’ trials—as opposed to showing more clustered means—because of the 
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instrument’s ability to show more of the pill movement with respect to imaged anatomy. 
As opposed to ultrasound in which judgment of hyoid movement may be questionable if, 
for example, the transducer placement is not maintained midline sagittal, there are 
typically no unclear images in videofluoroscopy that might question pill progression 
through the duration of the swallow. 
 Given concerns regarding a limit to oropharyngeal swallowing time in healthy 
individuals, future research should focus on pill swallowing with individuals who have 
difficulty swallowing and older individuals. Many people with dysphagia and older 
individuals have co-occurring, multiple issues that require taking medications, making 
swallowing pills necessary and unavoidable. Although data from this study is not 
sufficiently robust to support coating a tablet with a pleasant sweetened citrus-flavored 
tastant to enact a shorter swallow in healthy individuals, it is possible that those with 
greater variability in oropharyngeal swallow time may experience a safer and easier pill-
swallowing experience with a citrus-flavored tastant. It is also possible that a tastant 
producing heightened chemesthesis, such as very sour lemon, that minimally alters the 
texture of the pill while maintaining the integrity of the tablet may reveal more promising 
results. Nevertheless, it is hopeful that with increased focus on methods to make 
swallowing pills easy and safe, a problem that plagues many individuals—both young 









Pill Swallowing in Healthy Adults 
 
In order to participate, it is required that you fit the following criteria: 
 
 Healthy adult between the ages of 18–55. 
 Able to swallow food, liquid, pills without any problems, such as 
choking. 
 Not currently taking calcium supplements. 
 
If your answer is YES to all of the above, you may be eligible to take part in 
the study, contingent upon passing a short screening questionnaire and 
making sure that you have adequate tongue and lip move ents. 
 
This study will involve 2 visits and that takes a total of 30–45 minutes. We 
will see how you swallow using real-time ultrasound imaging (an easy, safe 
assessment!). 
 
Study participants will not be discriminated on thebasis of gender, race, 








Screening Questionnaire—Pill Swallowing In Adults 
 
DIRECTIONS: Circle or fill in blanks, if applicable 
 
(1) Have you ever had an allergic reaction to calcium? 
 
YES NO 
(2) Have you taken any calcium supplements today? 
 
YES NO 




(4) Have you ever had kidney stones? 
 
YES NO 
(5) Are you taking any medications that may be contraindicated with increased 
calcium intake (gallium nitrate (Ganite), cellulose sodium phosphate (Calcibind), 
etidronate (Didronel) phenytoin (Dilantin) or a tetracycline antibiotic to treat an 
infection (such as doxycycline, minocycline, Vibramycin))? 
 
YES NO 
(6) Have you had a high-fiber meal today (e.g., bran, whole-grain cereal or bread, 




(7) Have you ever had a problem swallowing (dysphagia)? 
 
YES NO 
(8) Have you ever had any difficulty swallowing pills? YES NO 




(9) How many pills/vitamins do you take a day? 
 
___________ 
(10) Do you typically take your pill(s)/vitamin(s) with food? 
 
YES NO 
(11) Do you ever take your pill(s)/vitamin(s) with liquid? 
 
YES NO 
(12) Do ever feel like your pill(s)/vitamin(s) get stuck in your throat? 
 
YES NO 
(13) Do you have any major health issues that require you to take pills? YES NO 
• List conditions:_____________________________________ 
 
(14) Do you have any food allergies? YES NO 
• List food allergies: __________________________________ 
 
(15) Do you dislike the taste of oranges, lemons, or limes? 
 
YES NO 
(16) Are you allergic to any of the following: glycerin, sorbitol, xanthan gum, 
neotame, sodium citrate, citric acid, potassium sorbate, sodium 
benzoate,propylene glycol, N & A flavors, cellulose, croscarmellose, titanium 
dioxide, vegetable magnesium stearate, FD&C Yellow No 5 Lake, FD&C Blue 







Speech-Language Pathology Swallowing Questionnaire 
 
Ratings: 1—Normal, None, Never 
 2—Mild, A Little, Occasionally 
 3—Moderate, A Fair Bit, Often 
 4—Severe, Lots, Usually-Always 
 
1. Does saliva collect in your mouth? 1 2 3 4 
2 Do you notice drooling during the day?  1 2 3 4 
3. Do you notice drooling at night?  1 2 3 4 
4. Do you cough, choke, or awaken with nighttime secretions?  1 2 3 4 
5. Do you have difficulty swallowing liquids?  1 2 3 4 
6. Do you have difficulty swallowing purees, soft, or sticky food 
(e.g., mashed potatoes, rice, puddings)?  
1 2 3 4 
7. Do you have difficulty swallowing solids (e.g., meat, raw 
vegetables)?  
1 2 3 4 
8. Have you eliminated any foods from your diet because of 
difficulty swallowing?  
1 2 3 4 
9. Do you have excessive saliva?  1 2 3 4 
10. Do you have dry mouth?  1 2 3 4 
11. Are you a fast eater?  1 2 3 4 
12. Are you a slow eater?  1 2 3 4 
13. Has your taste sensation (for sweet, bitter, salty, etc.) changed?  1 2 3 4 
14. Do you experience discomfort with hot or cold temperatures?  1 2 3 4 
15. Do you experience discomfort with spicy food?  1 2 3 4 
16. Do you have difficulty chewing hard food (e.g., hard candy, raw 
vegetables)?  
1 2 3 4 
17. Does food spread all over your mouth; pocket in your cheeks?  1 2 3 4 
18. Does food or liquid ever come up through your nose?  1 2 3 4 
19. Does food or pills ever stick in your throat?  1 2 3 4 
20. Do you experience heartburn/indigestion?  1 2 3 4 
21. Does food or liquid ever back up into your mouth?  1 2 3 4 
22. Do you ever cough when you eat?  1 2 3 4 
23. Have you had episodes of choking or airway obstruction when 
eating?  
1 2 3 4 
24. Do you experience upper respiratory problems such as pneumonia 
or bronchitis?  
1 2 3 4 
25. Do you have pain when swallowing?  1 2 3 4 
 
Published in: Sonies, B.C., Weiffenbach, J.M., Atkinson, J.C., Brahim, J., Macynski, A., Fox, P.C. (1987).  
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